IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.
About IPO Scanner
IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.
Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.
Details of client bank account
For any query / feedback / clarifications, email at
[email protected].
Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.
© 2026 IPO Scanner. All rights reserved.
Want to stay updated?Subscribe to our newsletter
Optimi Health Corp.
Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners.
The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets.
Ticker, listing venue and issuer profile
Pricing terms and IPO milestones
Real-time price and trading activity
USD · NASDAQ:NASDAQ:OPTH
Key valuation ratios and metrics
Balance sheet strength and liquidity
Volatility versus the market
Historical financial performance
Market history and supplemental quote data
| Date | Open | High | Low | Close | Adj. Close | Change | Volume |
|---|---|---|---|---|---|---|---|
| 2026-05-29 | $5.70 | $6.08 | $5.60 | $5.97 | $5.97 | +0.27 | 145,700 |
| 2026-05-28 | $5.57 | $5.75 | $5.54 | $5.65 | $5.65 | +0.08 | 25,400 |
| 2026-05-27 | $5.82 | $5.82 | $5.46 | $5.51 | $5.51 | -0.31 | 21,400 |
| 2026-05-26 | $5.80 | $5.91 | $5.37 | $5.71 | $5.71 | -0.09 | 113,200 |
| 2026-05-22 | $5.45 | $6.12 | $5.45 | $5.85 | $5.85 | +0.40 | 477,900 |
| 2026-05-21 | $5.51 | $5.82 | $4.95 | $5.70 | $5.70 | +0.19 | 468,200 |
| 2026-05-20 | $5.50 | $6.40 | $5.20 | $6.08 | $6.08 | +0.58 | 2,237,900 |
Official documents from SEC EDGAR
No SEC filings available for this IPO yet.
Contact and headquarters details
Key executives and officers
Dane Stevens
Co-Founder, Chief Executive Officer, Chief Marketing Officer and Director
John James Wilson
Co-Founder and Chairman
Bryan Edward Safarik
Co-Founder, Chief Operating Officer and Director
Dr. Preston A. Chase
Chief Science Officer
Ann Little
Human Resources Manager
Leah Hodges
Corporate Secretary

Shares
3.22M shares
Listing Price
$5.50
Probable listing
May 20, 2026
Sector
Healthcare